Papillary muscles identified by myocardial contrast echocardiography in preparation for percutaneous transluminal septal myocardial ablation
暂无分享,去创建一个
[1] U. Gleichmann,et al. Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: Detection of threatening myocardial necrosis distant from the septal target area , 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[2] U. Gleichmann,et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. , 1998, Circulation.
[3] D. Fassbender,et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. , 1998, Journal of the American College of Cardiology.
[4] M. Sherrid,et al. Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy. , 1998, Circulation.
[5] R. Gorlin,et al. A reappraisal of papillary muscle dysfunction; correlative clinical and angiographic study. , 1969, The American journal of medicine.
[6] M. Entman,et al. The anatomy and blood supply of the papillary muscles of the left ventricle. , 1966, American heart journal.